Company News & Press
Metabolon, Inc. has entered into a multi-year collaborative agreement with Cleveland Clinic to provide Metabolon’s Precision Metabolomics™ services in support of drug development and related research efforts. Metabolon will leverage its proprietary platform to analyze a range of biologic samples to help discover metabolomic biomarkers that will deepen understanding of Cleveland Clinic’s novel discoveries, improve speed of decision-making and accelerate clinical trials.
23 November 2020
GEN Genetic Engineering & Biotechnology News - Metabolon says that its Precision Metabolomics™ platform can improve quality control, data curation, and knowledge building. According to William LeFew, PhD, Metabolon’s director of data science, the company uses machine learning to automate routine tasks and teachable processes so its scientists can focus their efforts on the challenges that most require their expertise.
23 November 2020
“We are honored to partner with NIAID and Metabolon in this effort to define how the human response to SARS-CoV-2 correlates to COVID severity and outcome. Metabolic features of the immune responses are increasingly recognized as pivotal to disease and health, and we are fortunate to have Metabolon’s excellent team by our side as we undertake this critical work.” – Dr. Ofer Levy, Director of the Precision Vaccines Program (PVP) at Boston Children’s Hospital
25 January 2022
January 25-27, 2022 Santa Clara Convention Center Silicon Valley, CA PMWC, the “Precision Medicine World Conference” is the largest &...
11 February 2021
February 11th 10:00 am EDT/16:00 CET Studying the interactions between microbes and hosts have been enabled by a multitude of...
20 January 2021
January 20th 10:00 am EDT/16:00 CEST Successful drug development hinges on multimillion-dollar decisions about the mechanism of action, safety, dosage,...
18 November 2020
November 18th 9:00 am EDT/15:00 CEST How are researchers studying COVID-19 using metabolomics to get closer to the phenotype? Seven...
23 September 2020
September 23rd 7:00 am EDT/13:00 CEST Across the globe, 37.9 million people are living with HIV (PLWH). With access to...
21 September 2020
Visit us at booth 610 Connect with 2000+ global scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production.
14 September 2020
September 14th 12:00 pm EDT Metabolomics offers researchers the ability to get closer to the phenotype by identifying small molecules...
Join Metabolon’s Annie Evans, Ph.D., Director of R&D, and Greg Michelotti, Ph.D., Scientific Director of Biology, for our webinar: Proteomics and Metabolomics: A Technology Overview. During this event, we will compare and contrast how best to leverage these technologies to advance your research.
IGES is the International Genetic Epidemiology Society, a scientific society concerned with “the study of genetic components in complex biological phenomena” according to James V. Neel, the founding President of the Society. The successful mapping of the human genome will greatly facilitate the study of health and disease in a manner that integrates both host and environmental factors.
27 May 2020
Join Metabolon’s Patricia Sheridan, Ph.D., Senior Study Director, Discovery & Translational Sciences, for a conversation with Dr. Heath on May 27th at 11:00 am EDT/13:00 CEST. They will be discussing some of the current work that ISB is doing to explore COVID-19 infections and how metabolomics can be used to understand the pathophysiology of the infection.